Remus Pharmaceuticals Limited reported significant financial growth for the half-year ended September 30, 2024, with total revenue increasing to Rs. 27,555.54 Lakhs, a 797.60% rise from the previous year, and a profit after taxes of Rs. 1,401.12 Lakhs, up 148.09%. The company also declared a 10% interim dividend.